CIK: 0001306923 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 14, 2023
Total Value ($000): $1,172,888 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,885,811 | $195,163 | 16.6% | $83.16 | +12.9% | COM | 09061G101 |
| UTHR | UNITED THERAPEUTICS CORP | 625,414 | $173,921 | 14.8% | $89.23 | +182.9% | COM | 91307C102 |
| FOLD | AMICUS THERAPEUTICS INC | 10,493,722 | $128,128 | 10.9% | $9.63 | +17.0% | COM | 03152W109 |
| INSM | INSMED INC | 5,871,291 | $117,308 | 10.0% | $17.79 | +8.6% | COM | 457669307 |
| BIIB | BIOGEN INC | 380,082 | $105,252 | 9.0% | $264.98 | +6.6% | COM | 09062X103 |
| PRTA | PROTHENA CORP PLC | 1,658,577 | $99,929 | 8.5% | $21.46 | +172.9% | COM | G72800108 |
| — | REVANCE THERAPEUTICS INC | 5,283,609 | $97,535 | 8.3% | $21.40 | — | COM | 761330109 |
| STAA | STAAR SURGICAL CO | 1,240,077 | $60,193 | 5.1% | $19.87 | +215.7% | COM | 852312305 |
| ACAD | ACADIA PHARMACEUTICALS INC | 2,376,369 | $37,832 | 3.2% | $28.53 | -45.2% | COM | 004225108 |
| — | SAGE THERAPEUTICS INC | 856,517 | $32,668 | 2.8% | $46.62 | — | COM | 78667J108 |
| — | KARYOPHARM THERAPEUTICS INC | 5,655,676 | $19,229 | 1.6% | $16.36 | — | COM | 48576U106 |
| ALKS | ALKERMES PLC | 603,400 | $15,767 | 1.3% | $22.36 | +7.0% | COM | G01767105 |
| ALGN | ALIGN TECHNOLOGY INC | 74,605 | $15,734 | 1.3% | $149.18 | +34.2% | COM | 016255101 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 612,600 | $15,591 | 1.3% | $16.84 | +38.5% | COM | 87164F105 |
| ANAB | ANAPTYSBIO INC | 431,024 | $13,357 | 1.1% | $19.06 | +48.2% | COM | 032724106 |
| EHTH | EHEALTH INC | 2,484,479 | $12,025 | 1.0% | $41.23 | -91.0% | COM | 28238P109 |
| VNDA | VANDA PHARMACEUTICALS INC | 1,087,607 | $8,037 | 0.7% | $11.21 | -13.2% | COM | 921659108 |
| CYTK | CYTOKINETICS INC | 111,717 | $5,119 | 0.4% | $6.71 | +539.8% | COM | 23282W605 |
| — | KEZAR LIFE SCIENCES INC | 656,200 | $4,620 | 0.4% | $5.16 | — | COM | 49372L100 |
| — | PROVENTION BIO INC | 390,800 | $4,131 | 0.4% | $4.50 | — | COM | 74374N102 |
| TVTX | TRAVERE THERAPEUTICS INC | 166,069 | $3,492 | 0.3% | $23.56 | -10.0% | COM | 89422G107 |
| — | GRITSTONE ONCOLOGY INC | 666,127 | $2,298 | 0.2% | $9.42 | — | COM | 39868T105 |
| — | PEAK BIO INC | 497,528 | $2,022 | 0.2% | $4.06 | — | COM | 70470P108 |
| MIRM | MIRUM PHARMACEUTICALS INC | 64,700 | $1,262 | 0.1% | $15.56 | +27.1% | COM | 604749101 |
| ALDX | ALDEYRA THERAPEUTICS INC | 160,800 | $1,119 | 0.1% | $7.10 | -19.4% | COM | 01438T106 |
| — | ALIMERA SCIENCES INC | 200,919 | $544 | 0.0% | $6.30 | — | COM | 016259202 |
| TCMD | TACTILE SYSTEMS TECHNOLOGY I | 27,100 | $311 | 0.0% | $39.74 | -77.9% | COM | 87357P100 |
| URGN | UROGEN PHARMA LTD | 24,500 | $217 | 0.0% | $27.01 | -64.9% | COM | M96088105 |
| GOSS | GOSSAMER BIO INC | 37,750 | $82 | 0.0% | $11.85 | -30.5% | COM | 38341P102 |